NCT07338721

Brief Summary

This single-center randomized controlled trial evaluates whether detecting the first lymph node at the axillary entrance with ultrasound guidance, followed by a targeted axillary incision over the pencil-marked projection, improves sentinel lymph node identification compared to the conventional axillary hairline landmark. The study hypothesizes that this technique enables a smaller incision, minimizes tissue dissection, and reduces operative time.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
2mo left

Started Jan 2026

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress77%
Jan 2026Jun 2026

Study Start

First participant enrolled

January 1, 2026

Completed
3 days until next milestone

First Submitted

Initial submission to the registry

January 4, 2026

Completed
10 days until next milestone

First Posted

Study publicly available on registry

January 14, 2026

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 15, 2026

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

June 15, 2026

Last Updated

January 15, 2026

Status Verified

January 1, 2026

Enrollment Period

4 months

First QC Date

January 4, 2026

Last Update Submit

January 14, 2026

Conditions

Keywords

Breast cancerAxillaSentinel Lymph Node BiopsyUltrasonography

Outcome Measures

Primary Outcomes (1)

  • Intraoperative assessment of surgical performance parameters.

    Measurements will include incision details and lymph node detection times.

    Until completion of the sentinel lymph node procedure

Study Arms (2)

The ultrasound-guided axillary incision group.

In the ultrasound-guided axillary incision group, the incision is made parallel to the Langer lines under ultrasound guidance, targeting the projection of the first lymph node at the axillary entry.

Procedure: Ultrasound-guided axillary incision group

The standard hairline axillary incision group

In the ultrasound-guided axillary incision group, the incision is made at the ultrasound-identified projection of the first lymph node at the axillary entry.

Procedure: The standard axillary incision

Interventions

In the ultrasound-guided axillary incision group, the incision is made at the ultrasound-identified projection of the first lymph node at the axillary entry.

The ultrasound-guided axillary incision group.

In the standard group, the SLNB incision is made parallel to the Langer lines below the axillary hairline.

The standard hairline axillary incision group

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients scheduled for sentinel lymph node biopsy due to breast cancer at Antalya Training and Research Hospital.

You may qualify if:

  • \* Patients with clinical stage T1-T3 disease (tumor ≤5 cm), pN0-pN1 (one to three regional lymph nodes with micrometastases or metastases), and M0 (no distant metastasis) are eligible. Post-neoadjuvant yT1-T3, yN0-yN1, and M0 status are also eligible. All patients are undergoing axillary staging.
  • Clinically negative axilla
  • Written informed consent must be obtained prior to inclusio

You may not qualify if:

  • Younger than 18 years
  • Previous breast malignancy
  • Pregnancy
  • Pre-operative diagnosis of axillary lymph node metastases
  • The presence of multiple clinically involved or suspicious lymph nodes
  • Unable or unwilling to provide informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Antalya Training and Research Hospital

Antalya, 07100, Turkey (Türkiye)

RECRUITING

Related Publications (5)

  • Fenech M, Burke T, Arnett G, Tanner A, Werder N. Sonographic localisation of lymph nodes suspicious of metastatic breast cancer to surgical axillary levels. J Med Radiat Sci. 2025 Mar;72(1):119-138. doi: 10.1002/jmrs.840. Epub 2024 Nov 17.

    PMID: 39552171BACKGROUND
  • Suami H, Pan WR, Mann GB, Taylor GI. The lymphatic anatomy of the breast and its implications for sentinel lymph node biopsy: a human cadaver study. Ann Surg Oncol. 2008 Mar;15(3):863-71. doi: 10.1245/s10434-007-9709-9. Epub 2007 Nov 28.

    PMID: 18043970BACKGROUND
  • Gentilini OD, Botteri E, Sangalli C, Galimberti V, Porpiglia M, Agresti R, Luini A, Viale G, Cassano E, Peradze N, Toesca A, Massari G, Sacchini V, Munzone E, Leonardi MC, Cattadori F, Di Micco R, Esposito E, Sgarella A, Cattaneo S, Busani M, Dessena M, Bianchi A, Cretella E, Ripoll Orts F, Mueller M, Tinterri C, Chahuan Manzur BJ, Benedetto C, Veronesi P; SOUND Trial Group. Sentinel Lymph Node Biopsy vs No Axillary Surgery in Patients With Small Breast Cancer and Negative Results on Ultrasonography of Axillary Lymph Nodes: The SOUND Randomized Clinical Trial. JAMA Oncol. 2023 Nov 1;9(11):1557-1564. doi: 10.1001/jamaoncol.2023.3759.

    PMID: 37733364BACKGROUND
  • Veronesi U, Paganelli G, Galimberti V, Viale G, Zurrida S, Bedoni M, Costa A, de Cicco C, Geraghty JG, Luini A, Sacchini V, Veronesi P. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet. 1997 Jun 28;349(9069):1864-7. doi: 10.1016/S0140-6736(97)01004-0.

    PMID: 9217757BACKGROUND
  • Tanis PJ, Nieweg OE, Valdes Olmos RA, Kroon BB. Anatomy and physiology of lymphatic drainage of the breast from the perspective of sentinel node biopsy. J Am Coll Surg. 2001 Mar;192(3):399-409. doi: 10.1016/s1072-7515(00)00776-6.

    PMID: 11245383BACKGROUND

MeSH Terms

Conditions

Breast Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Study Officials

  • Baris R KARAKAS, Assoc. Prof.

    Antalya Training and Research Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
2 Weeks
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assoc. Prof.

Study Record Dates

First Submitted

January 4, 2026

First Posted

January 14, 2026

Study Start

January 1, 2026

Primary Completion (Estimated)

May 15, 2026

Study Completion (Estimated)

June 15, 2026

Last Updated

January 15, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

Locations